US$ 25.40
glp 1 and 2 agonist GLP-1 receptor agonists in the treatment of type diabetes – state-of-the-art Trends in the Development of
Description
None of the included human studies was found to have a high risk of bias (Table 3)

Now What

Obesity leads to significant SM changes
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
